Abigail Marie the Chef with IBD
Professional Chef with IBD helping you navigate food, lifestyle, new IBD research, and patient advocacy.
Zeposia, or ozanimod, was found effective in UC patients compared to placebo after only one week of full dose ingestion. This is a new drug on the autoimmune scene as it was approved for treatment of Multiple Sclerosis (MS) in June of 2020, but has proven itself a contender in treating UC after Bristol Myer … Read more
As more and more drugs come to market for autoimmune disorders the market gets fiercer and demanding. The current sweet spot? Taking autoimmune therapies from intravenous to pill form. This is seen across a wide range of autoimmune diseases from Multiple Sclerosis (MS) to IBD and everything in between. Zeposia was FDA approved for treatment … Read more